Macrogenics Inc (NAS:MGNX)
$ 4.36 0.25 (6.07%) Market Cap: 273.08 Mil Enterprise Value: 107.83 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 60/100

MacroGenics Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 07:50PM GMT
Release Date Price: $8.21 (+1.11%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

So first and foremost, thanks for everybody attending. It's the first conference in a couple of years we're back to in person. So thanks for the enthusiasm and support. And thank you so much, Scott, for attending and all your time.

Scott Koenig
MacroGenics, Inc. - CEO, President & Director

Always a pleasure.

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Always a pleasure to chat with you.

Scott Koenig
MacroGenics, Inc. - CEO, President & Director

Same here.

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

We've only got 25 minutes though. That's the only...

Scott Koenig;Peter Richard Lawson
MacroGenics, Inc. - CEO, President & Director;

Absolutely. So you only get to ask one question, I think.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot